- Home
- FBLA vs INBX Comparison
FBLA vs INBX Comparison
Compare FBLA & INBX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FBLA
- INBX
- Stock Information
- Founded
- FBLA 1908
- INBX 2010
- Country
- FBLA United States
- INBX United States
- Employees
- FBLA N/A
- INBX N/A
- Industry
- FBLA
- INBX Biotechnology: Pharmaceutical Preparations
- Sector
- FBLA
- INBX Health Care
- Exchange
- FBLA NYSE
- INBX Nasdaq
- Market Cap
- FBLA 227.1M
- INBX 168.1M
- IPO Year
- FBLA N/A
- INBX 2020
- Fundamental
- Price
- FBLA $10.64
- INBX $11.47
- Analyst Decision
- FBLA
- INBX Hold
- Analyst Count
- FBLA 0
- INBX 1
- Target Price
- FBLA N/A
- INBX N/A
- AVG Volume (30 Days)
- FBLA 117.3K
- INBX 142.9K
- Earning Date
- FBLA 01-01-0001
- INBX 05-08-2025
- Dividend Yield
- FBLA N/A
- INBX 7.56%
- EPS Growth
- FBLA N/A
- INBX N/A
- EPS
- FBLA N/A
- INBX 112.62
- Revenue
- FBLA $64,935,000.00
- INBX $200,000.00
- Revenue This Year
- FBLA N/A
- INBX N/A
- Revenue Next Year
- FBLA N/A
- INBX N/A
- P/E Ratio
- FBLA N/A
- INBX $0.10
- Revenue Growth
- FBLA N/A
- INBX N/A
- 52 Week Low
- FBLA $9.81
- INBX $10.80
- 52 Week High
- FBLA $12.74
- INBX $18.95
- Technical
- Relative Strength Index (RSI)
- FBLA N/A
- INBX 34.68
- Support Level
- FBLA N/A
- INBX $10.81
- Resistance Level
- FBLA N/A
- INBX $12.06
- Average True Range (ATR)
- FBLA 0.00
- INBX 1.00
- MACD
- FBLA 0.00
- INBX -0.19
- Stochastic Oscillator
- FBLA 0.00
- INBX 18.52
About FBLA FB BANCORP INC
FB Bancorp Inc is a holding company. It operates through its subsidiary Fidelity Bank. Fidelity business consists primarily of taking deposits from the general public and investing those deposits, together with funds generated from operations, in one- to four-family residential mortgage loans secured by properties located in primary market areas. Its services also include residential construction loans, commercial real estate loans (which includes commercial mortgage, commercial construction and land development loans), commercial loans (which includes commercial and industrial, small business and other commercial loans not secured by real estate), home equity loans and lines of credit, and consumer loans.
About INBX Inhibrx Inc.
Inhibrx Biosciences Inc is a clinical-stage biopharmaceutical company with a pipeline of novel biologic therapeutic candidates, developed using its proprietary modular protein engineering platforms. Its clinical pipeline of therapeutic candidates includes INBRX-109 and INBRX-106, both of which utilize their multivalent formats where the precise valency can be optimized in a target-centric way to mediate what experts consider to be the predominant agonist function.